This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AN COT EE ADS CMG

IBM (IBM) earnings estimates were reduced through 2014 to reflect weak hardware sales at Citigroup.

IBM earnings were cut primarily to reflect the $400M of transactional deals that did not close in the quarter and weak IT spending trends, said Deutsche Bank. Price target was reduced $225.

Morgan Stanley (MS) estimates were reduced at UBS. Morgan Stanley earnings estimates were cut for 2013 given the first quarter miss and weaker securities revenue, said UBS.

Microsoft (MSFT) earnings estimates were increased for 2013 at UBS. Gross margins are beginning to stabilize as the company gains scale.

NetFlix (NFLX) estimates were increased at Lazard. NetFlix estimates increased through 2013, Lazard Capital Markets said. Q1 report may swing ability to deliver sub growth. Buy rating and $200 price target.

Vertex Pharmaceutical (VRTX) price target was increased at Deutsche Bank. Vetex' price target was increased to $100, said Deutsche Bank. F508del homozygous and other Kalydeco mutations are now expected to have a 100% success rate.

Verizon (VZ)VZ Verizon earnings estimates were increased through 2014 to reflect strong Q1 wireless results, said Citigroup. The opportunity for a possible LBO of Vodafone's stake in Verizon Wireless remains on the table. Price target goes to $56.

Follow TheStreet on Twitter and become a fan on Facebook.

>To submit a news tip, email:
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AN $48.20 0.00%
ADS $200.24 0.00%
CMG $435.00 0.00%
COT $14.01 0.00%
EE $45.57 0.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs